Picture of China Medical System Holdings logo

867 — China Medical System Holdings News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Brief: China Medical System Says 'Tildrakizumab' Granted Approval For Drug Clinical Trial

Aug 19 (Reuters) - China Medical System Holdings Ltd
 0867.HK :
    * 'TILDRAKIZUMAB' GRANTED APPROVAL FOR DRUG CLINICAL TRIAL
ISSUED
FROM NMPA

Source text for Eikon:  ID:nHKS4ydH9n 
Further company coverage:  0867.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on China Medical System Holdings

See all news